Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis. Today, our panel of experts will explore the treatment landscape and impact of multiple sclerosis ...
Multiple sclerosis is a disease that may affect any area of the nervous system, thus causing a wide variety of symptoms such as visual problems, weakness, or numbness. Although the exact cause is ...
DUBLIN--(BUSINESS WIRE)--The "Primary Progressive Multiple Sclerosis (PPMS) - An Overview" report has been added to Research and Markets' offering. The report provides an overview of primary ...
DUBLIN--(BUSINESS WIRE)--The "Secondary Progressive Multiple Sclerosis (SPMS) - Disease Overview and Epidemiology" report has been added to Research and Markets' offering. This report provides an ...
Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.
Use of medical informatics for management of multiple sclerosis using a chronic-care model, pg. 1 The authors describe how the Multiple Sclerosis (MS) Centers of Excellence use healthcare information ...
DelveInsight'sā Multiple Sclerosis Pipeline Insight 2025ā report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Multiple Sclerosis pipeline landscape. It covers the ...
A multidisciplinary panel of experts provide an overview of the progressive nature of multiple sclerosis (MS) and discuss how clinicians, payers, and pharmacists approach management of the disease. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results